A Phase 1, Randomized, Double-blind, Multi-center, Placebo-controlled Trial to Evaluate the Safety and Immunogenicity of the Intramuscular Norovirus GI.1/GII.4 Bivalent VLP Vaccine in Healthy Japanese Infants 5 Months of Age at First Trial Vaccine Administration
Phase: PHASE1
Conditions: Gastroenteritis
Sponsor: HilleVax

Trial number: NOR-109 
Protocol Title: A Phase 1, Randomized, Double-blind, Multi-center, Placebo-controlled Trial to Evaluate 
the Safety and Immunogenicity of the Intramuscular Norovirus GI.1/GII.4 Bivalent VLP Vaccine in 
Healthy Japanese Infants 5 Months of Age at First Trial Vaccine Administration 
 
NCT:06007781